Krish S Krishnan

CIK 1298709 · President and CEO · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$484.68M

Companies

3

Total Filings

41

Lifetime Open-Market Net

-$125.42M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KRYS President and CEO 1,524,293 $317.97 $484.68M -$124.68M 36 2026-06-05
PRECIGEN, INC. (XON) Delisted Chief Operating Officer 113,314 -$745.4K 4 2016-02-01
NEW RIVER PHARMACEUTICALS INC (NRPH) Delisted COO, CFO and Secretary $0 1 2007-01-31

Recent Filings · Page 4 of 5

41 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-02-20 KRYS Sell (S) −50,000 -$3.10M EDGAR
2019-11-19 KRYS Sell (S) −50,000 -$2.56M EDGAR
2018-10-22 KRYS Buy (P) +25,000 $500.0K EDGAR
2018-06-05 KRYS Other (J) +26,213 $0 EDGAR
2018-03-19 KRYS Buy (P) +50,000 $550.0K EDGAR
2017-09-25 KRYS Mixed +212,162 $1.00M EDGAR
2016-02-01 PRECIGEN, INC. (XON) Delisted Exer (M) +29,314 $201.7K EDGAR
2015-12-04 PRECIGEN, INC. (XON) Delisted Sell (S) −20,900 -$745.4K EDGAR
2015-05-20 PRECIGEN, INC. (XON) Delisted Exer (M) +84,000 $598.1K EDGAR
2014-03-24 PRECIGEN, INC. (XON) Delisted Grant (A) $0 EDGAR
Showing 3140 of 41
Page 4 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.